QIAGEN today announced it has entered into a definitive agreement to fully acquire Parse Biosciences, a leading provider of scalable, instrument-free solutions for single-cell research. The ...
Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed withour AI-Immunology™ ...
Therapeutics Startup Helex Secures USD 3.5 Mn to Develop Targeted Kidney Treatments Helex, a therapeutics startup focused on genetic kidney diseases, has raised USD 3.5 million in a seed funding round ...
Senthilnathan K, founder of Sudotank Inc., is redefining enterprise AI with a focus on responsibility, transparency, and ...
Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from ...
Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from small lesions or polyps, its exact causes are unknown — only a few risk factors ...
SANTA CLARA, CA, UNITED STATES, October 7, 2025 /EINPresswire.com/ -- Sequoia Applied Technologies will launch GenXFlo, a low-code platform for designing ...
bbPharmacy Department, Parc Sanitari Sant Joan de Déu (PSSJD), Carrer del Dr. Antoni Pujadas, 42, 08830 Sant Boi de Llobregat, Spain bcCentre for Statistics in Medicine, Nuffield Department of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback